Exelixis
ABOUT US
We are shaping the future of oncology for patients.
1851 Harbor Bay Parkway
Alameda, CA 94502
(503) 804-5087
cabometyxhcp.com
PRIMARY CONTACTS
Joan Gratton
Senior Director National Accounts - Federal
(503) 804-5087
jgratton@exelixis.com
Tasha Hall
Medical Director
(412) 680-5256
thall@exelixis.com
PRODUCTS OR SERVICES
cabozantinib has 3 indications in:
* Advanced RCC: In combination with nivolumab to treat renal cell carcinoma (RCC) that has spread (advanced RCC), and you have not already had treatment for your advanced RCC
Alone to treat people with renal cell carcinoma (RCC) that has spread (advanced RCC)
* 2nd line HCC
PRODUCTS OR SERVICES
* DTC:Adults and children 12 years of age and older who have a type of thyroid cancer called differentiated thyroid cancer (DTC) that has spread (locally advanced or metastatic), and,
has progressed after treatment with a VEGFR-targeted treatment, and
your DTC can no longer be treated with radioactive iodine, or you are not able to receive radioactive iodine treatment.